Position in ARDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,186,682
+$1,949,938 QoQ
Shares Held
2,389,546
+39.8% QoQ
Ownership
0.959%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 250 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ARDX ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ARDX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,186,682 | 2,389,546 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $10,236,744 | 1,708,973 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,751,834 | 2,358,806 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $15,898,220 | 2,885,340 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,186,928 | 2,343,605 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $15,743,116 | 3,206,338 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,278,007 | 2,421,698 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $21,596,607 | 3,134,486 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $22,569,788 | 3,045,856 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $17,583,579 | 2,408,710 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $19,871,666 | 3,205,108 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $12,798,478 | 3,136,883 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $4,873,801 | 1,437,701 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,386,077 | 1,541,979 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,007,823 | 1,406,254 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $822,831 | 691,456 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $234,476 | 397,422 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $305,026 | 285,073 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,012,832 | 1,829,848 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,009,627 | 2,280,023 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,497,018 | 197,496 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $88,157 | 13,317 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,467,387 | 226,799 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $170,819 | 32,537 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $182,278 | 26,341 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,872,325 | 681,148 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||